Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
Clinical trial NCT00557232 · COMPLETED
Trial details
- NCT number
- NCT00557232
- Sponsor
- Instituto de Olhos de Goiania
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2011-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.